Frederick National Laboratory: 'Pan-KRAS' Drug Aiming at KRAS-Related Cancers Lacking Targeted Therapies Now Being Tested in Humans
July 16, 2025
July 16, 2025
FREDERICK, Maryland, July 16 -- The National Institutes of Health's National Laboratory for Cancer Research issued the following news:
* * *
'Pan-KRAS' drug aiming at KRAS-related cancers lacking targeted therapies now being tested in humans
By Mary Ellen Hackett
Patients with intractable cancers driven by mutations of the KRAS oncogene have few available therapies. Yet, an investigational compound co-developed by Frederick Natio . . .
* * *
'Pan-KRAS' drug aiming at KRAS-related cancers lacking targeted therapies now being tested in humans
By Mary Ellen Hackett
Patients with intractable cancers driven by mutations of the KRAS oncogene have few available therapies. Yet, an investigational compound co-developed by Frederick Natio . . .